Thymic peptides and microsurgery in Maksimov’s ocular-trauma program
I. B. Maksimov · 1996 · Doctoral dissertation author abstract. Moscow, 1996.
Reported findings and study design
Narrative findings; numerical extraction incomplete
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Severe injury subgroup | 119 patients and 186 eyes in the narrative. The table lists 150 patients and 186 eyes. | |
| Visual and structural recovery | The author reported recovery in parts of the surgical program. Effects of individual preparations were not isolated. |
Source for these results ↗ · Reviewed 2026-11-10
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The abstract combines microsurgery and multiple preparations. The severe-injury narrative and table disagree on the number of people, while both give 186 eyes.
- No reliable preparation-specific visual outcome or dose can be assigned to the 119-person subgroup.
Source access
Russian author-abstract transcription and named treatments reviewed. The full dissertation and arm-level outcomes were not recovered.
Source reviewed 2026-11-10.
Source type: Dissertation author abstract
Citation and original source
Original source: I. B. Maksimov. Thymic peptides and microsurgery in Maksimov’s ocular-trauma program Doctoral dissertation author abstract. Moscow, 1996. 1996.
Molekul research summary: https://molekul.io/research/maksimov-eye-trauma-thymic-peptides-1996. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Thymalin
Thymus-derived peptide mixture with historical Russian studies in autoimmune cytopenias and thyroiditis, alongside other treatments. It is distinct from synthetic Thymogen and Thymodepressin.
Thymogen
EW is discussed in the thymus-derived research program. Thymalin extract outcomes cannot be assigned to this defined peptide.